Clinical Trial Update: Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating autologous stem cell transplantation using Zevalin with BEAM conditioning for lymphoma; results were posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-11